Company Name: Proteostasis Therapeutics, Inc.   

Proteostasis Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in the development of therapeutics designed to control/rebalance the proteostasis network, with an initial focus on cystic fibrosis.

Ticker Symbol: PTI (NASDAQ)

Company Website: www.proteostasis.com

Social Media:

Proteostasis Therapeutics LinkedIn

Proteostasis Therapeutics Twitter

Headquarters: Cambridge, MA